Oregon Public Employees Retirement Fund Seagen Inc. Transaction History

Oregon Public Employees Retirement Fund

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 26, 2023	SELL	$191.51 - $216.16 $1.34 Million - $1.51 Million	-6,991 Reduced 30.32%	16,068 $3.41 Million
Q2 2023 Jul 26, 2023	BUY	$187.64 - $206.25 $4.33 Million - $4.76 Million	23,059 New	23,059 $4.44 Million
Q3 2021 Oct 19, 2021	SELL	$142.45 - $169.82 $170,940 - $203,784	-1,200 Closed	0 $0
Q2 2021 Jul 23, 2021	SELL	$135.08 - $161.1 $1.44 Million - $1.72 Million	-10,685 Reduced 89.9%	1,200 $189,000
Q4 2020 Feb 09, 2021	BUY	$164.63 - $211.93 $1.96 Million - $2.52 Million	11,885 New	11,885 $2.08 Million

1.26M

23K

55.2K

Ticker SGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,664,992
Description
Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...

Get notified when there are updates to the investment portfolio of Oregon Public Employees Retirement Fund, based on Form 13F filings with the SEC.

Stay updated on Oregon Public Employees Retirement Fund with notifications on news.